Literature DB >> 24163680

Pattern dystrophy of the macula in a case of steinert disease.

Filipe Esteves1, Rosa Dolz-Marco, Pablo Hernández-Martínez, Manuel Díaz-Llopis, Roberto Gallego-Pinazo.   

Abstract

INTRODUCTION: Myotonic dystrophies are typically associated with ocular complications like ptosis, weakness of the ocular muscle and cataracts, but also with less recognized retinal changes. CASE REPORT: A 41-year-old female with type 1 myotonic dystrophy complained of progressive vision loss. Slit lamp examination revealed the presence of typical bilateral polychromatic cataract with posterior subcapsular component. Dilated fundus examination was remarkable for bilateral macular depigmented changes. Multimodal imaging analysis of the macula suggested the presence of a butterfly-shaped pattern dystrophy. DISCUSSION: In cases of myotonic dystrophies it is of great relevance to analyze the presence of retinal changes that might limit the visual improvement following cataract extraction.

Entities:  

Keywords:  Acquired vitelliform deposit; Maculopathy; Myotonic dystrophy; Pattern dystrophy; Steinert disease

Year:  2013        PMID: 24163680      PMCID: PMC3806677          DOI: 10.1159/000355385

Source DB:  PubMed          Journal:  Case Rep Ophthalmol        ISSN: 1663-2699


Introduction

Pattern dystrophies of the retinal pigment epithelium (RPE) represent a group of heterogeneous disorders characterized by the development of a variety of patterns of yellow-orange-grayish pigment deposition above the RPE within the macular area [1]. These have traditionally been subdivided into 4 major patterns: butterfly dystrophy, reticular dystrophy, fundus pulverulentus and adult-onset foveomacular vitelliform dystrophy. The phenotype may vary among affected family members and even between the 2 eyes of the same patient [2]. The age of onset is highly variable, although most patients tend to remain asymptomatic until the fourth or fifth decade. The course is usually benign, but the disease may progress, leading to geographic atrophy of the RPE and/or choroidal neovascularization, therefore resulting in severe vision loss. Pattern dystrophies have been occasionally associated with a variety of systemic disorders. Among these, myotonic dystrophy is an inherited disorder accompanied by progressive wasting and weakness of the distal muscles and myotonia. It is typically associated with ocular complications including ptosis, weakness of the ocular muscle and cataracts [3, 4, 5]. Herein, we report a clinical case illustrating the association of a pattern dystrophy of the RPE with type 1 myotonic dystrophy.

Case Report

A 41-year-old Hispanic female diagnosed with type 1 myotonic dystrophy (Steinert disease) was referred for ophthalmologic examination with the chief complaint of progressive vision loss. Her best-corrected visual acuity was 20/32 in her right eye and 20/40 in her left eye. Ocular motility was normal. She had bilateral ptosis with abnormal elevator function. Slit lamp examination revealed the presence a bilateral polychromatic cataract with posterior subcapsular component. Dilated fundus examination was remarkable for macular pigmentary changes with multifocal yellowish depigmented patches within the macular area in both eyes (fig. 1). Fundus autofluorescence highlighted a branching linear pattern of mixed hyper- and hypoautofluorescence limited to the macular area in both eyes (fig. 1).
Fig. 1

Color photographs (a, b) show bilateral asymmetric irregular diffuse hypopigmented macular changes associated with focal hyperpigmented areas. A radial pattern of hyperautofluorescence was seen in the short-wavelength fundus autofluorescent images (c, d), consistent with butterfly-shaped macular pattern dystrophy. These lesions were associated with hypoautofluorescent patches corresponding to the areas of RPE hypertrophy.

Optical coherence tomography images showed diffuse subretinal hyperreflective material between the photoreceptor layer and the RPE in both eyes. Larger focal vitelliform lesions were also evidenced. No subretinal or intraretinal fluid was found in association with the deposits (fig. 2).
Fig. 2

The near-infrared fundus autofluorescence images (a, b) show a radial hyperautofluorescent pattern overlying a hypoautofluorescent background (butterfly-shaped macular pattern). Spectral-domain optical coherence tomography scans (c–f) reveal the presence of a diffuse subretinal hyperreflective material replacing the normal interdigitation zone with adjacent areas of mottled disruption of the outer retinal layers and focal hyperreflective subretinal deposits consistent with acquired vitelliform deposits.

Discussion

Type 1 myotonic dystrophy (Steinert disease) is a chronic, slowly progressing, highly variable, multisystemic disease produced by the expansion of the cytosine-thymine-guanine (CTG) triplet repeat in the DMPK gene (chromosome 19), which codes for myotonic dystrophy protein kinase [6, 7]. It is clinically characterized by muscular dystrophy, heart conduction defects, endocrine changes and myotonia. Although several reports previously described the ocular involvement in myotonic dystrophies, the majority of them refer to palpebral ptosis, cataract or ocular motility changes [3, 4, 5]. Very few publications raise the concern of retinal involvement in these patients with anecdotal reports about lamellar macular holes and foveoschisis [8], pigmentary changes of the RPE [9, 10, 11, 12] or uveal melanoma [13]. In conclusion, although myotonic dystrophies are typically associated with cataracts, ophthalmologists should be aware of the presence of retinal changes that might limit the visual improvement following cataract extraction.

Disclosure Statement

The authors have no conflicts of interest to disclose.
  12 in total

1.  Localisation of the myotonic dystrophy locus to 19q13.2-19q13.3 and its relationship to twelve polymorphic loci on 19q.

Authors:  H G Harley; K V Walsh; S Rundle; J D Brook; M Sarfarazi; M C Koch; J L Floyd; P S Harper; D J Shaw
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

2.  Butterfly-shaped pattern dystrophy in myotonic dystrophy.

Authors:  Shinji Makino; Yuko Ohkubo; Hironobu Tampo
Journal:  Intern Med       Date:  2012-08-15       Impact factor: 1.271

Review 3.  [Ocular disturbances in neuromuscular disorders].

Authors:  I Pénisson-Besnier; C Lamirel
Journal:  Rev Neurol (Paris)       Date:  2008-04-18       Impact factor: 2.607

4.  Spider dystrophy as an ocular manifestation of myotonic dystrophy.

Authors:  Amber C Louprasong; Dennis J Light; Rebecca S Diller
Journal:  Optometry       Date:  2010-04

5.  Association between uveal melanoma and myotonic dystrophy: a series of 3 cases.

Authors:  Juan P Velazquez-Martin; Charles J Pavlin; E Rand Simpson
Journal:  JAMA Ophthalmol       Date:  2013-02       Impact factor: 7.389

Review 6.  The myotonic dystrophies: diagnosis and management.

Authors:  Chris Turner; David Hilton-Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-02-22       Impact factor: 10.154

Review 7.  Myotonic Dystrophy Type 1 or Steinert's disease.

Authors:  Vincenzo Romeo
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

8.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.

Authors:  M Mahadevan; C Tsilfidis; L Sabourin; G Shutler; C Amemiya; G Jansen; C Neville; M Narang; J Barceló; K O'Hoy
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

9.  Retinal changes in myotonic dystrophy. Clinical and follow-up evaluation.

Authors:  Y Kimizuka; M Kiyosawa; M Tamai; S Takase
Journal:  Retina       Date:  1993       Impact factor: 4.256

10.  A novel RDS/peripherin gene mutation associated with diverse macular phenotypes.

Authors:  Zhenglin Yang; Yang Li; Li Jiang; Goutam Karan; Darius Moshfeghi; Scott O'Connor; Xi Li; Zhengya Yu; Hilel Lewis; Donald Zack; Samuel Jacobson; Kang Zhang
Journal:  Ophthalmic Genet       Date:  2004-06       Impact factor: 1.803

View more
  1 in total

1.  Fundus flavimaculatus-like in myotonic dystrophy: a case report.

Authors:  Eric Kirkegaard-Biosca; Mònica Berges-Marti; Brahim Azarfane; Esther Cilveti; Laura Distefano; Jose García-Arumí
Journal:  BMC Ophthalmol       Date:  2021-05-29       Impact factor: 2.209

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.